Literature DB >> 1970681

Identification of EBV-DNA in lymph nodes from patients with lymphadenopathy and lymphomas associated with AIDS.

B B Chappuis1, H Müller, J Stutte, M M Hey, K Hübner, H K Müller-Hermelink.   

Abstract

Fourteen examples of non-Hodgkin's lymphoma (NHL) and four of Hodgkin's disease in patients with AIDS as well as lymph nodes exhibiting changes related to the lymphadenopathy syndrome (LAS) from 11 HIV-positive individuals were studied for the presence of Epstein-Barr virus (EBV) genome both by in situ DNA hybridization and blotting techniques. Both methods were performed using formalin-fixed paraffin-embedded material. All the NHLs were of high malignancy and all but one were of the B-cell type. Of the four examples of Hodgkin's disease, two were lymphocytic predominant, one of mixed cellularity and one of the nodular sclerosing variety. The lymph nodes of patients with LAS were mostly stage I with marked follicular hyperplasia. In 7 of the 14 NHLs the presence of EBV-DNA was clearly demonstrated by dot-blotting and by in situ hybridization. All lymph nodes from the patients with LAS and AIDS-related Hodgkin's disease were negative for EBV by dot-blot and in situ hybridization assays. We conclude that EBV plays a role in the development of AIDS-related lymphomas, but the fact that half these lymphomas are EBV-negative suggests that other mechanisms such as polyclonal stimulation of B-cells by HIV products may also be important.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970681     DOI: 10.1007/bf02890072

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  6 in total

1.  Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients.

Authors:  B Borisch-Chappuis; C Nezelof; H Müller; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

2.  Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas.

Authors:  R H Edwards; N Raab-Traub
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 3.  Malignant tumours in patients with HIV infection.

Authors:  U Tirelli; S Franceschi; A Carbone
Journal:  BMJ       Date:  1994-04-30

4.  Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.

Authors:  S J Hamilton-Dutoit; D Rea; M Raphael; K Sandvej; H J Delecluse; C Gisselbrecht; L Marelle; H J van Krieken; G Pallesen
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

5.  Detection of Epstein-Barr virus genome in primary cutaneous T and B cell lymphomas and pseudolymphomas.

Authors:  K Peris; H Niedermeyer; L Cerroni; T Radaskiewicz; S Chimenti; H Höfler
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

6.  Epstein-Barr virus and HIV play no direct role in persistent generalized lymphadenopathy syndrome.

Authors:  M J Boyle; T B Sculley; D A Cooper; J J Turner; R Penny; W A Sewell
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.